Skip to main content

Reimbursement

By HIMSS TV | 09:35 am | December 03, 2021
This week's top stories include baby tech company Owlet pulling its connected-sock wearables following an FDA warning letter, and TeamHealth's victory in a lawsuit accusing UnitedHealthcare of engaging in unfair reimbursement practices.
By HIMSS TV | 07:00 am | November 16, 2021
Gravie Pay wants healthcare billing without "gotchas," says Ben Simmons, VP of insurance at Gravie.
By Emily Olsen | 12:45 pm | October 13, 2021
Around two million people receive coverage through Massachusetts' Medicaid program.
By HIMSS TV | 10:04 am | September 24, 2021
This week's top stories include projections that hospitals could lose $54 billion this year, Apple looking to add a feature that could detect potential mental illness, and a link found between ransomware and increased mortality rate.
By Mallory Hackett | 12:51 pm | August 19, 2021
The company has $6 million in seed funding from Lightspeed Venture Partners, Define Ventures and Qiming Venture Partners USA.   
By Emily Olsen | 12:53 pm | August 05, 2021
Also: Kenshō Health, which helps patients find holistic healthcare providers, raised another $3.5 million.
By Emily Olsen | 06:44 pm | August 02, 2021
Researchers found patients who used reSET-O along with buprenorphine and counseling lowered their healthcare costs by $2,385 per person in the six months after they started using the app, compared with the six months before.
By HIMSS TV | 09:39 am | June 11, 2021
This week's top stories include UnitedHealthcare re-examining a policy that allows it to deny ER claims, Apple unveiling walking stability assessments for the iPhone, and Mount Sinai catering to patients with limited English proficiency.
By Dave Muoio | 04:04 pm | April 01, 2021
Former CEO Ed Cox tells the story of Dthera Sciences and outlines how the digital therapeutics landscape has shifted since his company's heyday.
By Dave Muoio | 04:23 pm | March 03, 2021
Hillrom says that lower-than-expected reimbursement rates proposed in late January void the deal. But the cardiac-monitoring device maker asserts they were accounted for during negotiations.